Therefore, detection of changes in curvature based-metrics of the aortic valve leaflet due to abnormal elastin remodeling or loss could serve as a potential biomarker for early detection of CAVD. This evidence concerns the gene ELN and congenital bilateral aplasia of vas deferens from CFTR mutation.